NexgenRX Inc. Cash Flow Reinvestment Rate
NexgenRX Inc. cash flow reinvestment rate. NexgenRX Inc. (NXG) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CA$55.65K (capex CA$18.07K plus investments CA$-37.58K) from operating cash flow of CA$880.82K. Explore cash flow to debt ratio of NexgenRX Inc. to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of NexgenRX Inc. (2013–2024)
Cash flow reinvestment rate of NexgenRX Inc. from 2013 to 2024. Historical reinvestment intensity for NexgenRX Inc. across 8 annual periods. Explore NexgenRX Inc. (NXG) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
NexgenRX Inc. Cash Flow Reinvestment Rate by Year (2013–2024)
NexgenRX Inc. cash flow reinvestment rate by year from 2013 to 2024. Year-by-year capital reinvestment analysis for NexgenRX Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of NexgenRX Inc..
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CA$498.33K | CA$1.15 Million | CA$317.69K | ▲ +122.8% |
| 2023 | 0.19x | CA$248.41K | CA$1.28 Million | CA$248.41K | ▼ -76.8% |
| 2022 | 0.84x | CA$895.42K | CA$1.07 Million | CA$388.81K | ▲ +114.7% |
| 2021 | 0.39x | CA$1.50 Million | CA$3.82 Million | CA$126.55K | ▼ -13.4% |
| 2020 | 0.45x | CA$1.20 Million | CA$2.65 Million | CA$120.74K | ▼ -53.1% |
| 2019 | 0.96x | CA$1.01 Million | CA$1.05 Million | CA$50.78K | ▼ -33.4% |
| 2016 | 1.45x | CA$710.00K | CA$490.96K | CA$355.00K | ▲ +2269.5% |
| 2013 | 0.06x | CA$47.24K | CA$774.08K | CA$47.24K | — |